Mirena IUD manufacturer Bayer Healthcare Pharmaceuticals has filed a motion opposing the consolidation of federal Mirena lawsuits for purposes of pretrial proceedings, the Rottenstein Law Group, a Mirena law firm, reports according to court documents (In re: Mirena IUD Products Liability Litigation, MDL-2434 (JPML)).
Bayer argues in the Feb. 7 filing (In re: Mirena IUD Products Liability Litigation, MDL-2434 (JPML)) that multidistrict litigation would prejudice the company for several reasons, among them that because Bayer has been preparing documents for discovery in an individual case for the past two years, it would now have to spend further time and money to go through the process again for a federal MDL case. The company argues also that the creation of an MDL would attract “marginal” claims against the company over its Mirena hormonal IUD.
Mirena has demonstrated the potential to cause women serious side effects, according to the FDA drug label.* These include device perforation (puncture of the uterine wall), migration (the shifting of the device outside of the woman’s uterus), and embedment (the device becomes stuck in the uterine wall).
Read full story at PRWeb.com: Mirena Lawsuit Update: Bayer Opposes Federal Case Consolidation, Rottenstein Law Group Reports